Anton Belousov

Title: Anton Belousov: Innovator in Cancer Therapy and Chromatography

Introduction

Anton Belousov is a notable inventor based in Penzberg, Germany. He has made significant contributions to the fields of cancer therapy and chromatography. With a total of 3 patents to his name, Belousov's work is recognized for its innovative approaches to medical treatment and laboratory techniques.

Latest Patents

Belousov's latest patents include a GPC3-targeting drug designed to improve cancer treatment outcomes. This patent outlines a method for determining the efficacy of GPC3-targeting drug therapy in patients. It involves assessing the number of immunocytes or the expression level of specific molecules in biological samples. This method allows for informed decisions regarding the initiation or continuation of therapy based on predetermined values.

Another significant patent focuses on chromatography equipment characterization. This invention provides a method for evaluating the separation efficacy of reusable chromatography column packing. The process includes identifying physicochemical parameters and calculating differences to determine the effectiveness of the packing after multiple uses.

Career Highlights

Throughout his career, Anton Belousov has worked with prominent companies such as Hoffmann-La Roche Inc. and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has contributed to his expertise in drug development and purification processes.

Collaborations

Belousov has collaborated with notable professionals in his field, including Thomas Dams and Benjamin Gerwat. These partnerships have likely enhanced his research and development efforts.

Conclusion

Anton Belousov stands out as an innovative inventor whose work in cancer therapy and chromatography has the potential to make a significant impact in the medical and scientific communities. His patents reflect a commitment to advancing technology and improving patient outcomes.